Invesco Trust for New York Investment Grade Municipals
Change company Symbol lookup
Select an option...
VTN Invesco Trust for New York Investment Grade Municipals
VVR Invesco Senior Income Trust
CLX Clorox Co
SNCY Sun Country Airlines Holdings Inc
NCZ Virtus Convertible & Income Fund II
XPEV Xpeng Inc
PTON Peloton Interactive Inc
PEB Pebblebrook Hotel Trust
VFC VF Corp
BWG BrandywineGLOBAL ? Global Income Opportunities Fund
Go

Company profile

Invesco Trust for Investment Grade New York Municipals (the Trust) is a diversified, closed-end management investment trust. The Trust's investment objective is to provide common shareholders with a high level of current income exempt from federal, as well as from New York State and New York City income taxes, consistent with preservation of capital. Under normal market conditions, the Trust will invest over 80% of its total assets in New York municipal securities rated investment grade at the time of investment. Its investment advisor is Invesco Advisers, Inc. (Adviser). The Trust may invest up to 20% of its total assets in municipal securities rated on investment-grade or that are unrated but determined by the Adviser to be of comparable quality at the time of purchase.

Closing Price
$10.64
Day's Change
0.005 (0.05%)
Bid
--
Ask
--
B/A Size
--
Day's High
10.67
Day's Low
10.59
Volume
(Heavy Day)
Volume:
63,076

10-day average volume:
49,362
63,076

Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022

4:01 pm ET September 29, 2022 (PR Newswire) Print

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in the Cantor Neurology & Psychiatry Conference to be held at The Ritz-Carlton in San Francisco on October 6-7, 2022.

Payton Nyquvest, Founder and CEO of Numinus, will participate in the Digital-Pharma and a New Way of Thinking for NeuroPsych panel on Friday, October 7th at 9:00 a.m. PT.

In addition, Numinus will participate in the Cantor Symposium on Mental Health Clinics on Tuesday, October 11, 2022. Mr. Nyquvest will participate in a virtual fireside chat with Pablo Zuanic, Cantor Research Analyst, at 11:00 a.m. ET / 8:00 a.m. PT. To attend, please register here:https://us06web.zoom.us/webinar/register/WN_j0ChDwu_Tn6EFJfMUYjfqA

For more information about the conference, or to schedule a one-on-one meeting with Numinus' management, please contact your appropriate Cantor representative directly, or send an email to KCSA Strategic Communications NuminusIR@kcsa.com.

About NuminusNuminus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.

Forward-looking statementsStatements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

https://c212.net/c/img/favicon.png?sn=TO88674&sd=2022-09-29

View original content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-the-cantor-neurology--psychiatry-conference-on-october-6-7-2022-301637068.html

SOURCE Numinus Wellness Inc.

https://rt.prnewswire.com/rt.gif?NewsItemId=TO88674&Transmission_Id=202209291601PR_NEWS_USPR_____TO88674&DateId=20220929

comtex tracking

COMTEX_415584228/1005/2022-09-29T16:01:10

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.